Aemetis Does Not Benefit From The Iran War And Remains Highly Risky
Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $22
CPCFA Adopts Initial Resolution Supporting up to $1.1 Billion of Tax-Exempt Financing for Aemetis Projects
Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) 1Q26
Aemetis Inc (AMTX): Revenue Jumps and Indian Subsidiary IPO on Track
Aemetis Q1 Earnings Call Highlights
Aemetis (AMTX) Q1 2026 Earnings Transcript
Aemetis, Inc. (AMTX) Q1 2026 Earnings Call Transcript
Aemetis (AMTX) Reports Q1 Loss, Misses Revenue Estimates
Aemetis (NASDAQ:AMTX) Falls 4% Premarket After Q1 Miss on Revenue and Earnings
Aemetis Reports First Quarter 2026 Financial Results
Aemetis Q1 EPS $(0.33) Misses $(0.27) Estimate, Sales $54.619M Miss $67.268M Estimate
Aemetis to Review First Quarter 2026 Financial Results on May 7, 2026
Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $21
Buy Aemetis As It Hits Multiple Catalysts In 2026
Aemetis CEO Eric McAfee Receives Holmberg Award for Lifetime Achievement in the Bioeconomy
Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q425
Aemetis, Inc. Q4 2025 Earnings Call Summary
Aemetis Q4 Earnings Call Highlights
Aemetis (AMTX) Q4 2025 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.